Answer
Yes. Its licence covers primary hyperoxaluria type 1 in all age groups, although clinical data are limited in children younger than one year.
Sources for this answer
- Oxlumo 94.5 mg/0.5 mL solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.